Loading...
Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma
Purpose: The benefits of additional use of nimotuzumab (NTZ) in the treatment of locoregionally advanced nasopharyngeal carcinoma (LA-NPC) is largely unclear. We aim to compare LA-NPC treatment outcomes in patients that received CCRT with nimotuzumab (NTZ) to patients that received CCRT only. Materi...
Na minha lista:
| Udgivet i: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301798/ https://ncbi.nlm.nih.gov/pubmed/30081714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1491501 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|